Biocartis is a startup based in Belgium, most recent round Series-c-plus, 2 tracked investors.
Based in Belgium, Biocartis is a startup founded in 2011. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Biocartis is an innovative molecular diagnostics company that revolutionizes molecular testing with its proprietary Idylla™ platform, offering next-generation diagnostic solutions focused on oncology and infectious diseases to improve clinical practice and patient outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.